Where do Eli Lilly's ratios come from?

Every ratio is computed from Eli Lilly's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Eli Lilly LLY Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	331.5%+6.9pp	330.4%+7.3pp	328.7%+7.6pp	326.6%+7.7pp	324.7%+8.8pp
Net margin	123.5%+38.0pp	111.2%+31.3pp	103.1%+31.3pp	92.6%+25.7pp	85.5%+15.5pp
Returns
Return on equity	392.3%+105pp	362.4%+101pp	345.8%+120pp	314.7%+108pp	287.7%+74.5pp
Return on invested capital	147%+49.6pp	130.3%+38.8pp	118.5%+35.8pp	104.7%+26.6pp	97.4%+15.4pp
Efficiency
Asset turnover	2.6×+0.1×	2.6×+0.1×	2.5×+0.1×	2.5×+0.1×	2.5×+0.1×
Liquidity
Current ratio	5.9×+1.0×	5.8×+0.9×	5.4×+0.7×	5.1×+0.6×	4.9×+0.4×
Leverage
Debt-to-equity	7×-2.2×	8×-0.8×	8.9×0.0×	9.3×+0.8×	9.2×+1.2×
Net debt / EBITDA	5.7×-3.5×	6.9×-2.7×	7.8×-2.5×	8.8×-1.5×	9.2×-0.4×
Per Share
Book value per share	$111.11+73.5%	$93.79+54.5%	$80.07+40.9%	$69.33+29.4%	$64.02+26.0%
Valuation
Market capitalization	$3.17T+3.8%	$3.09T+2.6%	$2.82T-1.7%	$2.93T+14.9%	$3.05T+41.2%
Price / earnings	166.9×-172×	201.1×-185×	220.1×-206×	278.3×-149×	338.8×-42.8×
Price / sales	50.8×-20.3×	54.5×-20.9×	55.2×-21.0×	63.2×-8.5×	71×+5.9×
Price / book	129.6×-82.3×	150.3×-69.3×	162.7×-59.6×	190×-19.3×	211.9×+24.6×
EV / EBITDA	130.5×-119×	154.9×-124×	169.2×-131×	209.7×-85.9×	249.8×-16.5×
Dividend yield	2.7%+0.3pp	2.7%+0.3pp	2.8%+0.4pp	2.6%-0.1pp	2.4%-0.6pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Eli Lilly.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Eli Lilly's ratios come from?: Every ratio is computed from Eli Lilly's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.